Genmab and Bolt Biotherapeutics Announce Oncology Research and Development CollaborationGlobeNewsWire • 06/02/21
Bolt Biotherapeutics Announces AACR 2021 Presentation of Boltbody™ Platform Mechanism of Action and Clinical Properties of Lead ISAC, BDC-1001GlobeNewsWire • 04/10/21
Bolt Biotherapeutics to Present at 20th Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/08/21
Bolt Biotherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business HighlightsGlobeNewsWire • 03/31/21
Bolt Biotherapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 02/09/21